Showing results (181-190 of 215) with videos related to
Sort By:
Pageof 22
Leukemia|June 25, 1998
RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-upR A Padua, B A Guinn, A I Al-Sabah, et al.Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|October 14, 2004
[Medical treatment of ectopic pregnancy: a randomized clinical trial comparing metotrexate-mifepristone and methotrexate-placebo]O Garbin, R de Tayrac, L de Poncheville, et al.Clinical and Experimental Immunology|January 5, 2013
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptorV Gouilleux-Gruart, H Chapel, S Chevret, et al.Journal of Hepatology|August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 GroupF Degos, V Daurat, S Chevret, et al.Leukemia|July 23, 2004
A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patientsP Rousselot, J Larghero, B Arnulf, et al.Journal of Crohn'S & Colitis|July 14, 2016
Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk PatientsM Simon, J Cosnes, J M Gornet, et al.Journal of Hepatology|November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 GroupS Naveau, A Balian, F Degos, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 18, 2015
Adenovirus infection and disease in paediatric haematopoietic stem cell transplant patients: clues for antiviral pre-emptive treatmentL Feghoul, S Chevret, A Cuinet, et al.Experimental Hematology|November 8, 2001
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplantsV Rocha, M V Carmagnat, S Chevret, et al.Pageof 22